Skip to content
DraconiticResearch
Search Sources API
209,918 studies31 sourcesUpdated 46 min ago
PreprintCC BY-NCbioRxiv

High-dimensional HIV-1 quasispecies modeling guides escape-proof antibody design

  1. 1Utrecht University

Abstract

Rapidly evolving viruses form diverse quasispecies that enable escape from immune responses and treatments. For example, HIV-1 can rebound within weeks of broadly neutralizing antibody (bNAb) treatment through the outgrowth of high-fitness escape mutants in the quasispecies or the evolution of new escape variants. Most existing models of viral dynamics consider only a small number of viral variants and either assume arbitrary mutant fitness distributions or require extensive fitting to sparse clinical data. Here, we develop a high-dimensional HIV-1 quasispecies model that captures the dynamics of millions of viral strains and parameterize this using in silico binding affinity predictions. Without fitting to experimental data, the model qualitatively reproduces viral rebound following bNAb treatment. Lower-dimensional model projections recover these dynamics only when informed by features derived from the high-dimensional model. Finally, we use the model to develop a quasispecies-based framework for antibody optimization and identify antibodies predicted to effectively suppress viremia. Together, our results demonstrate that integrating mechanistic genotype-phenotype maps with high-dimensional quasispecies models provides unprecedented insights into viral evolution.

Related

  1. A sunflower FLS2 guides reconstruction of recognition of a Xanthomonas flg22 escape variant across divergent FLS2 receptors
    L. Zhong, L. Wu, Q. Cheng
    bioRxivPreprintCC BY-NC-NDFull textPlant biologybioRxiv
  2. Prophylactic treatment with broadly neutralizing antibody VRC01 selects for escape mutants after infection in Antibody-Mediated Prevention trials
    Carolyn Williamson, Lyle Curry, Nonhlanhla N. Mkhize +46
    Nature MicrobiologyPeer-reviewedCC BY 4.0Full textMicrobiologyPMC
  3. Genetic accessibility, not superior fitness, determines which anti-HBs antibody escape variants are selected in patients
    Y. Yu, E. Michailidis, L. L. Seifert +17
    bioRxivPreprintCC BYFull textMicrobiologybioRxiv
  4. Sequence-only antigen context improves modeling of antibody hypervariable regions
    F. B. Ashraf, S. Lonardi
    bioRxivPreprintCC BY-NCFull textBioinformatics & computational biologybioRxiv
  5. Quasispecies relocate rather than drift: hierarchical genotype networks track viral adaptation
    Iker Atienza-Diez, Samuel Mart\'ınez-Alcalá, Luis F. Seoane +1
    arXivPreprintCC BY-NC-ND 4.0Full textEvolutionary biologyarXiv
BibTeX
@misc{dodd2026highdimensional,
  title = {{High-dimensional HIV-1 quasispecies modeling guides escape-proof antibody design}},
  author = {G. Kutler Dodd and P. Hogeweg and R. J. de Boer},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.02.748882},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.02.748882v1},
  note = {CC BY-NC},
}
RIS
TY  - UNPB
TI  - High-dimensional HIV-1 quasispecies modeling guides escape-proof antibody design
AU  - G. Kutler Dodd
AU  - P. Hogeweg
AU  - R. J. de Boer
PY  - 2026
DA  - 2026/09/02
PB  - bioRxiv
DO  - 10.64898/2026.09.02.748882
UR  - https://www.biorxiv.org/content/10.64898/2026.09.02.748882v1
AB  - Rapidly evolving viruses form diverse quasispecies that enable escape from immune responses and treatments. For example, HIV-1 can rebound within weeks of broadly neutralizing antibody (bNAb) treatment through the outgrowth of high-fitness escape mutants in the quasispecies or the evolution of new escape variants. Most existing models of viral dynamics consider only a small number of viral variants and either assume arbitrary mutant fitness distributions or require extensive fitting to sparse clinical data. Here, we develop a high-dimensional HIV-1 quasispecies model that captures the dynamics of millions of viral strains and parameterize this using in silico binding affinity predictions. Without fitting to experimental data, the model qualitatively reproduces viral rebound following bNAb treatment. Lower-dimensional model projections recover these dynamics only when informed by features derived from the high-dimensional model. Finally, we use the model to develop a quasispecies-based framework for antibody optimization and identify antibodies predicted to effectively suppress viremia. Together, our results demonstrate that integrating mechanistic genotype-phenotype maps with high-dimensional quasispecies models provides unprecedented insights into viral evolution.
ER  -